GREG CUNY to Drug Delivery Systems
This is a "connection" page, showing publications GREG CUNY has written about Drug Delivery Systems.
Connection Strength
0.075
-
A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466. Expert Opin Ther Pat. 2009 Jun; 19(6):893-9.
Score: 0.075